Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Veracyte, Inc. < Previous 1 2 3 4 5 Next > Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year June 27, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT New Data Show Strong Performance of Veracyte’s Afirma GSC in Real-World Clinical Practice June 20, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Data Published in Annals of Oncology Reinforce Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier for Informing Treatment of Men Experiencing Prostate Cancer Progression June 03, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces that New Data Show Immunoscore IC Assay May Predict Patients Likely to Benefit from Addition of Immunotherapy to Standard First-Line Therapy for Metastatic Colorectal Cancer May 31, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT New Data to be Shared at ASCO 2022 Underscore Clinical Utility of Decipher Prostate Genomic Classifier May 26, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assay’s Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors May 26, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte to Present at Upcoming Investor Conferences May 26, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment May 16, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Updated AUA/ASTRO Guideline Includes Supportive Statement for Use of Genomic Tests, Including Decipher Prostate, for Men With Localized Prostate Cancer May 12, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022 May 04, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces First Quarter 2022 Financial Results May 03, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis May 02, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference April 28, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference April 26, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022 April 19, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Appoints Annie McGuire as General Counsel February 28, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Appoints Jonathan Wygant as Chief Accounting Officer February 22, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022 February 15, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer February 14, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference February 08, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium January 31, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer January 24, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision January 06, 2022 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis December 14, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test November 24, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021 November 13, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces Third Quarter 2021 Financial Results November 09, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia November 05, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis November 03, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities November 02, 2021 From Veracyte, Inc. Via Business Wire Tickers VCYT < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.